2020
-
-
Dec 17, 2020 product/service
-
-
product/service
-
Announcement of an exclusive distribution agreement to supply COVID-19 detection kits(116 KB)
-
-
Dec 16, 2020 other
-
-
other
-
Regarding a Reduction of Directors’ Compensation and Compliance Enhancement Initiatives for Recurrence Prevention(148 KB)
-
-
Dec 11, 2020 product/service
-
-
product/service
-
Notice Regarding Launch of 2 Ingredients / 7 Products of Generic Drugs for KYOSOMIRAI PHARMA(111 KB)
-
-
Dec 09, 2020 other
-
-
other
-
Regarding accusation of a suspected violation of the Antimonopoly Act(113 KB)
-
-
Nov 06, 2020 performance
-
-
performance
-
Summary of Consolidated Financial Results for the First Half of Fiscal Year Ending March 2021(409 KB)
-
-
Oct 27, 2020 M&A/partnership
-
-
M&A/partnership
-
Announcement of Investment in Drawbridge Health, Inc.(83 KB)
-
-
Oct 13, 2020 other
-
-
other
-
Notice regarding the search of a consolidated subsidiary by the Tokyo District Public Prosecutors Office and the Japan Fair Trade Commission(76 KB)
-
-
Sep 16, 2020 other
-
-
other
-
Announcement of the launch of a large and highly-functional logistics center, “TBC Dynabase” – Achieving tremendous improvement in the efficiency of pharmaceutical distribution and disaster response in the Tokyo metropolitan area –(455 KB)
-
-
Sep 07, 2020 M&A/partnership
-
-
M&A/partnership
-
Notice Regarding Contract on Distribution Operation of of Treakisym®, an Antineoplastic Drug by SymBio Pharmaceuticals Limited(91 KB)
-
-
Aug 25, 2020 M&A/partnership
-
-
M&A/partnership
-
Announcement of Capital Alliance with enTouch KK(133 KB)
-
-
Aug 19, 2020 M&A/partnership
-
-
M&A/partnership
-
TOHO HOLDINGS CO., LTD. and Shionogi Pharma Co., Ltd. conclude a basic agreement on a business alliance in the active pharmaceutical ingredients business(98 KB)
-
-
Aug 17, 2020 product/service
-
-
product/service
-
Notice Regarding Marketing Approvals for 2 Ingredients / 7 Products of Generic Drugs for KYOSOMIRAI PHARMA(112 KB)
-
-
Jul 30, 2020 product/service
-
-
product/service
-
Notice Regarding Launch of 1 Ingredient / 3 Products of Generic Drugs for KYOSOMIRAI PHARMA(105 KB)
-
-
Jul 27, 2020 performance
-
-
performance
-
Summary of Consolidated Financial Results for the First Quarter of Fiscal Year Ending March 31, 2021(350 KB)
